2025-03-13 02:29:45
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Tatva Chintan Pharma Chem Ltd Q3FY23 consolidated profit up QoQ at Rs. 11.62 crores
Posted On : 2023-01-25 13:20:54( TIMEZONE : IST )
Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 122.127 crores during the period ended December 31, 2022 as compared to Rs. 91.64 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 11.623 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 7.112 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 5.24 for the period ended December 31, 2022 as compared to Rs. 3.21 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹122.127 crs | ₹91.64 crs |  33.27% |
| Net Profit | ₹11.623 crs | ₹7.112 crs | 63.43% |
| EPS | ₹5.24 | ₹3.21 | 63.24% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.122.127 crores during the period ended December 31, 2022 as compared to Rs.109.284 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.11.623 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.22.807 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.5.24 for the period ended December 31, 2022 as compared to Rs.10.29 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹122.127 crs | ₹109.284 crs | 11.75% |
| Net Profit | ₹11.623 crs | ₹22.807 crs |  -49.04% |
| EPS | ₹5.24 | ₹10.29 | -49.08% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.303.999 crores during the 9 Months period ended December 31, 2022 as compared to Rs.343.704 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.28.528 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.78.364 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.12.87 for the 9 Months period ended December 31, 2022 as compared to Rs.36.82 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹303.999 crs | ₹343.704 crs | -11.55% |
| Net Profit | ₹28.528 crs | ₹78.364 crs | -63.60% |
| EPS | ₹12.87 | ₹36.82 | -65.05% |
Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 2184.90 as compared to the previous close of Rs. 2142.55. The total number of shares traded during the day was 63 in over 32 trades.
The stock hit an intraday high of Rs. 2184.90 and intraday low of 2140.00. The net turnover during the day was Rs. 135315.00.
